MNKD compared with XPER: revenue, margins and what each company keeps, and the suppliers and customers both name

MNKDMannkind Corp

Mkt capRevenueRevenue

XPERXperi Inc.

Mkt capRevenueRevenue

Compare

MNKDMannkind Corp

XPERXperi Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MNKD: latest quarter is a loss; flow not drawable. XPER: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

MNKD, solidXPER, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MNKD 4

UTHRUnited Therapeuticssupplier

AMPHAmphastarsupplier

—Amphastar France Pharmaceuticals S.A.Sunlistedsupplier

—Ciplaunlistedcustomer

Shared 0

No shared counterparties.

Only XPER 1

PNCPNC Bank, National Associationsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MNKDMannkind Corp

3.73· pre 3.73· delayed

Mkt cap$1.2BRevenue$109MQ2 FY26Revenue$349MFY25

XPERXperi Inc.

5.43· pre 5.39· delayed

Pre-marketNov 3 '26delayed

Mkt cap$261.0MRevenue$114MQ2 FY26Revenue$448MFY25

Compare

Pre-marketNov 3 '26delayed

MNKDMannkind Corp

XPERXperi Inc.

3.73pre 3.73delayed

Price

5.43pre 5.39delayed

$1.2B

Mkt cap

$261.0M

Q2 FY26$109M

Revenue

$114MQ2 FY26

FY25$349M

Revenue

$448MFY25

MNKD3.73vsXPER5.43Pre-marketNov 3 '26delayed